Benoit Terris Selected Research

Fibrosis (Cirrhosis)

12/2019	[FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients].
10/2018	Influence of Progenitor-Derived Regeneration Markers on Hepatitis C Virus-Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort).
4/2011	Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans.
3/2010	Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis.
6/2008	Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benoit Terris Research Topics

Disease

30	Neoplasms (Cancer) 12/2023 - 05/2002
9	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 11/2002
7	Carcinogenesis 01/2023 - 11/2002
7	Neoplasm Metastasis (Metastasis) 06/2021 - 10/2004
5	Fibrosis (Cirrhosis) 12/2019 - 06/2008
4	Carcinoma (Carcinomatosis) 01/2020 - 10/2004
4	Pancreatic Neoplasms (Pancreatic Cancer) 11/2011 - 05/2002
3	Inflammation (Inflammations) 01/2023 - 03/2008
3	Urinary Bladder Neoplasms (Bladder Cancer) 10/2019 - 01/2017
3	Breast Neoplasms (Breast Cancer) 05/2013 - 10/2009
3	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 04/2011 - 01/2006
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2023 - 12/2019
2	Hepatitis 05/2023 - 11/2007
2	Esophageal Neoplasms (Esophageal Cancer) 12/2020 - 01/2019
2	Non-Muscle Invasive Bladder Neoplasms 10/2019 - 01/2017
2	Liver Neoplasms (Liver Cancer) 01/2016 - 02/2010
2	Hyperplasia 03/2010 - 01/2006
2	Adenocarcinoma 10/2004 - 09/2003
1	Liver Failure 12/2023
1	Chronic Hepatitis B 12/2023
1	Colorectal Neoplasms (Colorectal Cancer) 10/2023
1	Cholangiocarcinoma 10/2023
1	Cushing Syndrome 06/2023
1	Mesenchymal Chondrosarcoma 01/2023
1	Chondrosarcoma 01/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Barrett Esophagus (Barrett's Esophagus) 01/2023
1	Colitis 01/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	Adrenocortical Carcinoma 04/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Infections 06/2021
1	Multiple Myeloma 07/2020
1	Primitive Neuroectodermal Tumors (PNET) 12/2019
1	Fatty Liver 12/2019
1	Exocrine Pancreatic Insufficiency 10/2019
1	Lymphatic Metastasis 01/2019
1	Residual Neoplasm 01/2019
1	Thrombocytopenia (Thrombopenia) 03/2016
1	Portal Hypertension 03/2016
1	Hypoalbuminemia 03/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2016
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2015
1	Neuroendocrine Carcinoma 10/2015
1	Cholestasis 01/2015
1	Adenoma (Adenomas) 04/2014
1	Liver Cell Adenoma (Hepatocellular Adenoma) 04/2014
1	Cysts 04/2014

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2003
6	CateninsIBA 01/2023 - 02/2012
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2002
4	RNA (Ribonucleic Acid)IBA 01/2023 - 09/2009
3	Messenger RNA (mRNA)IBA 10/2019 - 01/2017
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2011 - 01/2006
3	beta CateninIBA 02/2010 - 11/2002
3	Complementary DNA (cDNA)IBA 10/2004 - 05/2002
2	InterferonsIBA 01/2023 - 03/2008
2	MucinsIBA 06/2021 - 01/2014
2	Epithelial Cell Adhesion MoleculeIBA 10/2018 - 02/2010
2	Lipocalin-2IBA 10/2004 - 05/2002
1	AntibodiesIBA 12/2023
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2023
1	Peptide Receptors (Peptide Receptor)IBA 09/2023
1	Chromogranin AIBA 09/2023
1	Everolimus FDA Link 09/2023
1	Sunitinib (Sutent)FDA Link 09/2023
1	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2023
1	Immune Checkpoint InhibitorsIBA 05/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Transaminases (Aminotransferases)IBA 01/2023
1	Azathioprine (Imuran)FDA LinkGeneric 01/2023
1	Dextran SulfateIBA 01/2023
1	ParaffinIBA 04/2022
1	N 30IBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 06/2021
1	Immunoglobulin G (IgG)IBA 07/2020
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	LigandsIBA 01/2017
1	Prothrombin (Factor II)IBA 03/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Oral ContraceptivesIBA 04/2014
1	Inhibins (Inhibin)IBA 04/2014

Therapy/Procedure

10	Therapeutics 10/2023 - 01/2006
3	Drug Therapy (Chemotherapy) 12/2023 - 01/2023
3	Liver Transplantation 03/2016 - 06/2008
2	Chemoradiotherapy 12/2020 - 10/2015
2	Esophagectomy 12/2020 - 01/2019
2	Pancreatectomy 12/2019 - 10/2019
2	Cystectomy 10/2019 - 01/2017
2	Immunotherapy 01/2017 - 01/2017
1	Aftercare (After-Treatment) 12/2023
1	Lymph Node Excision (Lymph Node Dissection) 10/2023
1	Radiotherapy 01/2023
1	Radiofrequency Ablation 01/2023
1	Transjugular Intrahepatic Portasystemic Shunt 05/2013